About

Computational Biology at the Intersection of AI and Life Sciences

Welcome to C2Bio — a research-focused blog covering the latest developments in applied AI/ML, computational biology, biosecurity, and synthetic biology. If you work at the intersection of computation and the life sciences, or simply want a curated weekly signal through the noise of biotech and AI research, you are in the right place.

About Me

I am a research scientist working on AI/ML applications in biology, with a focus on biosecurity and synthetic biology. My work sits at the boundary between computational methods and pressing biological challenges — building models that help us understand, predict, and respond to complex biological systems.

My path here is unconventional. I trained and practiced as a surgeon before transitioning into computational research — a shift driven by the recognition that some of the most consequential questions in medicine and biology are fundamentally computational problems. That clinical background shapes how I think about the work: rigor matters, and the distance between a model and a real-world outcome is never as large as we would like to believe.

I am based in New Mexico. Before this chapter, I founded C2Bio as a company — which has since been dissolved — but the domain and the name stuck, repurposed now as this blog.

What This Blog Covers

Each week, C2Bio publishes:

  • AI/ML in Biology — New preprints, methods, and tools applying machine learning to biological problems, from protein structure to genomics to drug discovery.
  • Biotech News — Clinical trial readouts, FDA decisions, and research findings worth paying attention to.
  • FDA Catalyst Brief — Weekly summary of upcoming PDUFA dates, regulatory decisions, and pipeline milestones.
  • Curated Weekly Digest — A hand-selected roundup of the most important developments across AI/ML and biotech, published every week.

Content is kept concise and technically grounded. The goal is not to cover everything — it is to surface what actually matters.

Follow C2Bio

If you find this blog useful, follow it via Blogger to receive updates when new posts are published. You can also reach me through the Contact page — I read every message, though responses may take a few days.

Subscribe via Substack Follow C2Bio LinkedIn

Comments

New comments are not allowed.

Popular posts from this blog

Controlled Sampling in High-Dimensional Latent Spaces for Protein Design

A fundamental challenge in generative artificial intelligence involves sampling from carefully constructed high-dimensional latent spaces and utilizing these samples as inputs to decoder networks for generating novel entities. In the context of computational protein design, this process typically involves sampling regions within protein embedding spaces where specific biochemical properties are anticipated, such as enhanced binding affinity or improved developability characteristics in therapeutic antibodies. The sample-decode paradigm presents several significant technical challenges that must be addressed for effective protein generation. First, determining the optimal sampling distance from training datasets remains a critical consideration—sampling too close may limit diversity, while sampling too far may compromise biological relevance. Second, identifying which directions in the latent space merit more extensive exploration requires careful consideration of the underlying protein...
Read more

First Impressions: Claude Code as an AI Coding Assistant

I was really impressed by Claude Code. For just $5 and under an hour, Claude scanned my project repository and generated the skeleton of a new functionality based on my prompt. While the code wasn’t error-free, the overall logic was sound. Reaching that point on my own would have taken me hours, if not days. About half of the errors could be resolved with additional prompting, and I spent roughly another hour fixing the remaining bugs and testing. In total, I had working, productive code in about four hours—work that would normally take me closer to twenty hours. In other words, that $5 effectively saved me 15 hours of effort!
Read more

Google Colab as a Cloud GPU Platform: Notes and First Impressions

After tracking Nvidia’s RTX 50-series cards for a while, I still feel they are too expensive and likely not powerful enough to fully support my AI enthusiasm. As a result, I’ve decided to explore alternatives, particularly cloud solutions. Google Colab has turned out to be a very appealing option for now. It provides a Jupyter Notebook interface backed by CPUs, GPUs, and TPUs managed by Google. There is a free tier that offers limited GPU access (availability-based). During my test run this Sunday morning, I was able to access a GPU with 16 GB of memory. Paid users receive access to more powerful GPU and CPU resources. This makes Colab a viable alternative to running an on-premise AI lab—provided you’re comfortable with Google hosting your data and models. I haven’t checked AWS’s GPU offerings yet, but based on my prior EC2 experience, I feel Colab is much more convenient. Colab simplifies many aspects (from billing to system management), allowing you, as an AI scientist, to focus on m...
Read more